These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 21243314)

  • 1. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.
    DosReis GA
    Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Evasion Strategies of Trypanosoma cruzi.
    Flávia Nardy A; Freire-de-Lima CG; Morrot A
    J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Host immune response to Trypanosoma cruzi and its evasion mechanism].
    Yamamoto M; Takeda K
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1053-8. PubMed ID: 21089540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is It Possible to Intervene in the Capacity of
    Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
    Front Immunol; 2021; 12():789145. PubMed ID: 34975884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
    Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
    Front Immunol; 2020; 11():1279. PubMed ID: 32695105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theft and Reception of Host Cell's Sialic Acid: Dynamics of
    da Fonseca LM; da Costa KM; Chaves VS; Freire-de-Lima CG; Morrot A; Mendonça-Previato L; Previato JO; Freire-de-Lima L
    Front Immunol; 2019; 10():164. PubMed ID: 30787935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles.
    Cestari I; Ansa-Addo E; Deolindo P; Inal JM; Ramirez MI
    J Immunol; 2012 Feb; 188(4):1942-52. PubMed ID: 22262654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles Shed By
    Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
    Front Immunol; 2018; 9():896. PubMed ID: 29755471
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Volpini X; Ambrosio LF; Fozzatti L; Insfran C; Stempin CC; Cervi L; Motran CC
    Front Immunol; 2018; 9():859. PubMed ID: 29743880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding CD8
    Acosta Rodríguez EV; Araujo Furlan CL; Fiocca Vernengo F; Montes CL; Gruppi A
    Trends Parasitol; 2019 Nov; 35(11):899-917. PubMed ID: 31607632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells in Trypanosoma cruzi infection.
    Tarleton RL
    Semin Immunopathol; 2015 May; 37(3):233-8. PubMed ID: 25921214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Lasso P; Mateus J; González JM; Cuéllar A; Puerta C
    Methods Mol Biol; 2019; 1955():349-361. PubMed ID: 30868540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
    de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM
    Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
    Campetella O; Buscaglia CA; Mucci J; Leguizamón MS
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165692. PubMed ID: 31972227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Trypanosoma cruzi persistence in Chagas disease.
    Nagajyothi F; Machado FS; Burleigh BA; Jelicks LA; Scherer PE; Mukherjee S; Lisanti MP; Weiss LM; Garg NJ; Tanowitz HB
    Cell Microbiol; 2012 May; 14(5):634-43. PubMed ID: 22309180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.
    Junqueira C; Caetano B; Bartholomeu DC; Melo MB; Ropert C; Rodrigues MM; Gazzinelli RT
    Expert Rev Mol Med; 2010 Sep; 12():e29. PubMed ID: 20840799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis.
    Ramírez-Toloza G; Sosoniuk-Roche E; Valck C; Aguilar-Guzmán L; Ferreira VP; Ferreira A
    Trends Parasitol; 2020 Apr; 36(4):368-381. PubMed ID: 32191851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.